Tromsø, Norway, 9[th] March 2022 - ArcticZymes Technologies ASA (OSE: AZT)
announces the establishment of a new application development laboratory at
ShareLab in Oslo.

ArcticZymes Technologies has signed an agreement with ShareLab AS to lease
laboratory facilities at its premises in the Oslo Science Park. These facilities
will support application development activities to demonstrate the utility of
the CompanyŽs enzymes in customer relevant workflows and technologies. This is
an essential part of the innovation process and strengthens the commercial value
proposition of the CompanyŽs product offerings.

ShareLab is a service platform provider of laboratory and office facilities to
biotechnology companies. It conveniently provides the necessary amenities and
shared core equipment suited to ArcticZymesŽ requirements which means minimal
capital investments to get started. Furthermore, ShareLabŽs location in the Oslo
Science Park is central to the Norwegian biotechnology industry and life science
research.

The Oslo location will allow access to a broad talent pool of commercially
-experienced application scientists. Also, as the Company continues to grow it
has strategic relevance to have part of ArcticZymes located at the heart of the
Norwegian biotech industry.

Dr. Darren Ellis has been hired to lead the activities at ShareLab and is
currently recruiting two application scientists. Dr. Ellis brings over 20 years
of industrial R&D experience (from Solexa (now Illumina) and Thermo Fisher
Scientific) in leading and developing molecular research and In Vitro Diagnostic
(IVD) applications, technologies, and products.  Furthermore, he has global
expertise in Business-to-Business (B2B) application development, successfully
helping commercial partners/customers to bring their technologies and product
developments to market.

ArcticZymes Technologies ASA, CEO, Jethro Holter said:

"ArcticZymes is delighted to welcome Dr. Ellis to lead this important expansion
into Oslo. The new applications team and laboratory are integral to the
CompanyŽs growth strategy to broaden the utility and relevance of ArcticZymesŽ
enzymes to its commercial customers.

ArcticZymes is proud to partner with ShareLab and become an active member of the
Oslo Biotech community."

ShareLab AS, Managing Partner, Esben A. Nilssen, said:

"ArcticZymes is Norway's premier industrial biotech company, and we are both
happy and proud to welcome them as new members of ShareLab. At ShareLab,
ArcticZymes will benefit from the interaction with biotech talents, life science
institutions, and companies located at and around ShareLab and Oslo Science
Park. Deep enzymes expertise is much sought after and ArcticZymes' presence at
ShareLab will undoubtedly cater for growth."

For more information, please contact:

ArcticZymes Technologies
CEO, Jethro Holter                  Tel: +47 46 85 91 46
CFO, Børge Sørvoll                  Tel: +47 95 29 01 87
                                      ir@arcticzymes.com
ShareLab
Managing Partner, Esben A. Nilssen     hello@sharelab.no
                                     (ShareLab mailroom)

About ArcticZymes Technologies ASA

ArcticZymes Technologies is a Norwegian life sciences company focused on the
development, manufacturing and commercialization of novel recombinant enzymes
for use in molecular research, In Vitro Diagnostics (IVD) and therapeutics.

Listed on the Oslo Stock Exchange since 2005 originally under the [Biotec]
ticker, as Biotec Pharmacon. The company rebranded as ArcticZymes Technologies
in 2020 under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at
the SIVA Innovation Centre.

ArcticZymes Technologies' IP and capabilities are protected via a large
portfolio of patents.

For more information, please visit the website: www.arcticzymes.com.

About ShareLab AS

ShareLab offers fully equipped and serviced wet labs for startups and industrial
partners, as well as a community of industry experts and biotech entrepreneurs.
The laboratory is located at Oslo Science Park amid Norwegian institutions like
University of Oslo, Oslo University Hospital, SINTEF, and a range of life
science companies. ShareLab is non-profit and will reinvest profits in cutting
edge laboratories and industrial knowhow to help fuel Norwegian life science.

For more information, please visit the website: www.sharelab.no